SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-053708
Filing Date
2022-10-14
Accepted
2022-10-14 18:53:32
Documents
2
Period of Report
2022-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1521
2 EX-24 DOCUMENT attachment1.htm EX-24 2276
  Complete submission text file 0001209191-22-053708.txt   5207
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address
Ndu Adora (Reporting) CIK: 0001865210 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 221312317